SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $534K invested in Scinai Immunotherapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$315K
2
+$47K
3
+$446
4
Morgan Stanley
Morgan Stanley
New York
+$87
5
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$43

Top Sellers

1
-$15.7K
2
-$14.9K
3
-$598
4
NC
NewSquare Capital
Pennsylvania
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$315K
2
$213K
3
$3.08K
4
$1.99K
5
$717
6
$139
7
$38
8
$17
9
$6
10
–
11
–
12
–
13
–